Facebook Twitter Instagram Linkedin Youtube
Facebook Twitter

Pandemic Latest News

Click Here

News

Indonesia launches domestic COVID-19 vaccination

Leave a Comment / covid, Featured, infectious diseases, News, Newsletter, sars-cov-2 /

Indonesia launched its first home-grown COVID-19 shot Thursday to help reduce the world’s fourth most populous nation’s dependency on imported vaccines. www.medscape.com/viewarticle/982435?src=wnl_edit_tpal&uac=398271FG&impID=4751294&faf=1 President Joko Widodo announced the vaccine brand, IndoVac, as a new milestone for Indonesia’s pharmaceutical industry that will manufacture primary series vaccines, booster vaccines and vaccines for children, which have been in development […]

Indonesia launches domestic COVID-19 vaccination Read More »

Omicron subvariants becoming dominant strains

Leave a Comment / covid, Featured, infectious diseases, News, Newsletter, sars-cov-2 /

The subvariants known as BQ.1.1, BQ.1, BQ.1.3, BA.2.3.20 and XBB are among the fastest spreading of the main Omicron lineages. Based on UK data, the BQ variants, as well as BA.2.75.2 and BF.7 are the most concerning due to their growth advantage and immune evasiveness, the US health security agency has said. BF.7 has also

Omicron subvariants becoming dominant strains Read More »

Maiden Pharma’s license suspended following cough syrup deaths

Leave a Comment / Featured, News, West Africa /

Indian authorities have suspended the licence of Delhi-based drugmaker, Maiden Pharma, after it failed to furnish information on cough syrup related deaths in West Africa’s The Gambia.The company is accused of supplying cough syrup that led to the deaths of 66 children in The Gambia.Meanwhile, police in The Gambia are investigating the deaths of 66

Maiden Pharma’s license suspended following cough syrup deaths Read More »

A new monoclonal antibody treatment for Alzheimer’s disease

Leave a Comment / Featured, News, Non Communicable Diseases /

The pharmaceutical companies Biogen and Eisai last week announced that a monoclonal antibody treatment reduced cognitive decline by 27% in people with early stage Alzheimer’s compared with those on a placebo after 18 months. www.science.org/content/article/news-glance-ai-regulation-renewable-energy-and-alzheimer-s-therapy? Lecanemab belongs to a class of therapies that break down or inhibit build up of amyloid plaques in the brain,

A new monoclonal antibody treatment for Alzheimer’s disease Read More »

COVID increasing once more in the UK

Leave a Comment / covid, Featured, infectious diseases, News, sars-cov-2 /

According to data from the Office for National Statistics (ONS), about one in 65 people in England – an estimated 857,400 individuals – had COVID in the week ending 17 September, up from 766,500 people, or one in 70, the week before. www.theguardian.com/global/2022/oct/06/rising-uk-covid-levels-whats-driving-it-and-what-will-happen-next? An increase was also seen in Wales, while in Northern Ireland and

COVID increasing once more in the UK Read More »

Zero-COVID policy continues to cause chaos in China

Leave a Comment / covid, Featured, infectious diseases, News, sars-cov-2 /

Lockdowns and travel restrictions are continuing to cause chaos across China in the run-up to a crucial political meeting next week as the government holds fast to hard-line zero-COVID policies. As thousands of Communist party delegates prepare to descend on Beijing for the twice-a-decade Congress meeting, where Xi Jinping is expected to start his third

Zero-COVID policy continues to cause chaos in China Read More »

Will COVID-19 resurge in Europe this winter?

Leave a Comment / covid, Featured, infectious diseases, News, sars-cov-2 /

A new COVID-19 wave appears to be brewing in Europe as cooler weather arrives, with public health experts warning that vaccine fatigue and confusion over types of available vaccines will likely limit booster uptake. www.medscape.com/viewarticle/981965?src=wnl_edit_tpal&uac=398271FG&impID=4728508&faf=1 Omicron subvariants BA.4/5 that dominated this summer are still behind the majority of infections, but newer Omicron subvariants are gaining

Will COVID-19 resurge in Europe this winter? Read More »

Uganda struggles with immunisation resistant Ebola strain

Leave a Comment / Ebola, Featured, infectious diseases, News /

Uganda is racing to contain an Ebola outbreak driven by a strain of the virus that is resistant to existing immunization shots. A celebrated vaccine that was effective in the Democratic Republic of Congo’s 2018-22 outbreak has proved unsuccessful against the Sudanese strain of the virus that is currently driving cases up.Two vaccine candidates could

Uganda struggles with immunisation resistant Ebola strain Read More »

How COVID-19 is able to evade our immune systems

Leave a Comment / covid, Featured, infectious diseases, News, sars-cov-2 /

While COVID-19 has fallen from the spotlight of media attention, the pandemic is far from over. Through a process referred to as immune evasion – or antibody escape – the virus has endured and continues to spread throughout the globe. With winter fast approaching, we could soon expect another wave. The hallmark waves of the

How COVID-19 is able to evade our immune systems Read More »

Monoclonal antibody marks first approved Alzheimer’s treatment in nearly twenty years

Leave a Comment / Featured, News, Non Communicable Diseases /

Earlier this week, the pharmaceutical companies Biogen and Eisai announced encouraging results from a clinical trial for patients with Alzheimer’s disease: a monoclonal antibody treatment, called lecanemab, reduced cognitive decline by 27% in people with early-stage Alzheimer’s compared with those on a placebo after a year and a half. Outside observers say the trial could

Monoclonal antibody marks first approved Alzheimer’s treatment in nearly twenty years Read More »

About Us

Health Issues Africa is a web portal that tracks key health stories and issues in Africa. On our website, you will find a guide to some of the latest trends, research, reports and journals on health. We provide original interviews and opinions of specialists as well as our own commentary on issues and events.
Facebook Twitter

Newsletter

Subscribe our newsletter to stay updated

Copyright © 2023 | Health Issues Africa | All rights reserved.